Adicet Bio Stock

adicetbio.comHealthcare / BioTech & PharmaFounded: 1900Funding to Date: $131MM

Adicet Bio is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases.

Register for Details

For more details on financing and valuation for Adicet Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Adicet Bio.

Register Today

Team

Management Team

Carrie Krehlik
Chief Human Resources Officer
Francesco Galimi MD
Chief Medical Officer & Senior Vice President
Brian Hogan
Chief Financial Officer
Aya Jakobovits Ph.D
Founder, Board Member & Senior Advisor
Anil Singhal Ph.D
Chief Executive Officer, President & Board Member
Stewart Abbot Ph.D
Chief Scientific Officer & Chief Operating Officer
Donald Santel
Chairman

Board Members

Asish Xavier Ph.D
Johnson & Johnson Innovation - JJDC
Erez Chimovits
OrbiMed
Michal Silverberg
Novartis Venture Fund
Carl Gordon
Donald Santel
Jonathan Silverstein
Aya Jakobovits Ph.D
Florent Gros
Novartis Venture Fund
Yair Schindel MD
aMoon Fund

Other companies like Adicet Bio in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.74B

News Highlights

aMoon invests in $80m Adicet Bio financing round
 
Updated on: Sep 24, 2023